Header Logo

Connection

MARIA REDONDO to Humans

Back to Details
This is a "connection" page, showing publications MARIA REDONDO has written about Humans.
MARIA REDONDO
Connection Strength
1.377
Humans
  1. Genetic Associations With C-peptide Levels Before Type 1 Diabetes Diagnosis in At-risk Relatives. J Clin Endocrinol Metab. 2025 Mar 17; 110(4):e1046-e1050.
    View in: PubMed
    Score: 0.027
  2. Type 1 Diabetes Genetic Risk Scores: History, Application and Future Directions. Curr Diab Rep. 2025 Feb 08; 25(1):22.
    View in: PubMed
    Score: 0.027
  3. Characteristics of autoantibody-positive individuals without high-risk HLA-DR4-DQ8 or HLA-DR3-DQ2 haplotypes. Diabetologia. 2025 Mar; 68(3):588-601.
    View in: PubMed
    Score: 0.026
  4. Age and sex mark clinical differences in the presentation of pediatric type 1 diabetes mellitus. J Pediatr Endocrinol Metab. 2025 Jan 29; 38(1):22-28.
    View in: PubMed
    Score: 0.026
  5. Diabetic ketoacidosis in youth with diabetes mellitus during the COVID-19 pandemic. J Pediatr Endocrinol Metab. 2024 Sep 25; 37(9):759-763.
    View in: PubMed
    Score: 0.026
  6. Reply to 'Slowly progressive insulin dependent diabetes mellitus in type 1 diabetes endotype 2'. Nat Rev Endocrinol. 2024 May; 20(5):313.
    View in: PubMed
    Score: 0.025
  7. Inaccurate diagnosis of diabetes type in youth: prevalence, characteristics, and implications. Sci Rep. 2024 04 17; 14(1):8876.
    View in: PubMed
    Score: 0.025
  8. Diabetes Study of Children of Diverse Ethnicity and Race: Study design. Diabetes Metab Res Rev. 2024 Mar; 40(3):e3744.
    View in: PubMed
    Score: 0.024
  9. Understanding diabetes heterogeneity: key steps towards precision medicine in diabetes. Lancet Diabetes Endocrinol. 2023 11; 11(11):848-860.
    View in: PubMed
    Score: 0.024
  10. Baseline leptin predicts response to metformin in adolescents with type 1 diabetes and increased body mass index. Diabetes Obes Metab. 2023 11; 25(11):3420-3423.
    View in: PubMed
    Score: 0.024
  11. Clinical Characterization of Data-Driven Diabetes Clusters of Pediatric Type 2 Diabetes. Pediatr Diabetes. 2023; 2023.
    View in: PubMed
    Score: 0.024
  12. Heterogeneity and endotypes in type 1 diabetes mellitus. Nat Rev Endocrinol. 2023 09; 19(9):542-554.
    View in: PubMed
    Score: 0.024
  13. Age Ain't Nothing But a Number . . . or Is It? Diabetes Care. 2023 06 01; 46(6):1135-1136.
    View in: PubMed
    Score: 0.024
  14. Phenotypes Associated With Zones Defined by Area Under the Curve Glucose and C-peptide in a Population With Islet Autoantibodies. Diabetes Care. 2023 05 01; 46(5):1098-1105.
    View in: PubMed
    Score: 0.024
  15. Milder loss of insulin-containing islets in individuals with type 1 diabetes and type 2 diabetes-associated TCF7L2 genetic variants. Diabetologia. 2023 01; 66(1):127-131.
    View in: PubMed
    Score: 0.023
  16. On the road to universal screening for risk of type 1 diabetes. Lancet Diabetes Endocrinol. 2022 08; 10(8):554-555.
    View in: PubMed
    Score: 0.022
  17. Type 1 diabetes in diverse ancestries and the use of genetic risk scores. Lancet Diabetes Endocrinol. 2022 08; 10(8):597-608.
    View in: PubMed
    Score: 0.022
  18. Spectrum of Phenotypes and Causes of Type 2 Diabetes in Children. Annu Rev Med. 2022 01 27; 73:501-515.
    View in: PubMed
    Score: 0.022
  19. Toward an Improved Classification of Type 2 Diabetes: Lessons From Research into the Heterogeneity of a Complex Disease. J Clin Endocrinol Metab. 2021 11 19; 106(12):e4822-e4833.
    View in: PubMed
    Score: 0.021
  20. Type 2 diabetes in prepubertal children. Pediatr Diabetes. 2021 11; 22(7):946-950.
    View in: PubMed
    Score: 0.021
  21. TCF7L2 Genetic Variants Do Not Influence Insulin Sensitivity or Secretion Indices in Autoantibody-Positive Individuals at Risk for Type 1 Diabetes. Diabetes Care. 2021 09; 44(9):2039-2044.
    View in: PubMed
    Score: 0.021
  22. Islet autoantibody types mark differential clinical characteristics at diagnosis of pediatric type 1 diabetes. Pediatr Diabetes. 2021 09; 22(6):882-888.
    View in: PubMed
    Score: 0.021
  23. Index60 as an additional diagnostic criterion for type 1 diabetes. Diabetologia. 2021 04; 64(4):836-844.
    View in: PubMed
    Score: 0.020
  24. The Evolution of Hemoglobin A1c Targets for Youth With Type 1 Diabetes: Rationale and Supporting Evidence. Diabetes Care. 2021 02; 44(2):301-312.
    View in: PubMed
    Score: 0.020
  25. Sex differences in circulating leptin as a marker of adiposity in obese or overweight adolescents with type 1 diabetes. BMJ Open Diabetes Res Care. 2020 10; 8(1).
    View in: PubMed
    Score: 0.020
  26. The clinical consequences of heterogeneity within and between different diabetes types. Diabetologia. 2020 10; 63(10):2040-2048.
    View in: PubMed
    Score: 0.020
  27. GLP-1 Receptor Agonist as Adjuvant Therapy in Type 1 Diabetes: No Apparent Benefit for Beta-Cell Function or Glycemia. J Clin Endocrinol Metab. 2020 08 01; 105(8).
    View in: PubMed
    Score: 0.019
  28. Decline Pattern of Beta Cell Function in LADA: Relationship to GAD Autoantibodies. J Clin Endocrinol Metab. 2020 08 01; 105(8).
    View in: PubMed
    Score: 0.019
  29. Challenges in the diagnosis of diabetes type in pediatrics. Pediatr Diabetes. 2020 11; 21(7):1064-1073.
    View in: PubMed
    Score: 0.019
  30. Single Islet Autoantibody at Diagnosis of Clinical Type 1 Diabetes is Associated With Older Age and Insulin Resistance. J Clin Endocrinol Metab. 2020 05 01; 105(5).
    View in: PubMed
    Score: 0.019
  31. Genetics of Type 1 Diabetes Comes of Age. Diabetes Care. 2020 01; 43(1):16-18.
    View in: PubMed
    Score: 0.019
  32. New insights on the genetics of type 1 diabetes. Curr Opin Endocrinol Diabetes Obes. 2019 08; 26(4):181-187.
    View in: PubMed
    Score: 0.018
  33. The Influence of Type 2 Diabetes-Associated Factors on Type 1 Diabetes. Diabetes Care. 2019 08; 42(8):1357-1364.
    View in: PubMed
    Score: 0.018
  34. Transcription Factor 7-Like 2 (TCF7L2) Gene Polymorphism and Progression From Single to Multiple Autoantibody Positivity in Individuals at Risk for Type 1 Diabetes. Diabetes Care. 2018 12; 41(12):2480-2486.
    View in: PubMed
    Score: 0.017
  35. A Type 1 Diabetes Genetic Risk Score Predicts Progression of Islet Autoimmunity and Development of Type 1 Diabetes in Individuals at Risk. Diabetes Care. 2018 09; 41(9):1887-1894.
    View in: PubMed
    Score: 0.017
  36. Response to Comment on Redondo et al. Racial/Ethnic Minority Youth With Recent-Onset Type 1 Diabetes Have Poor Prognostic Factors. Diabetes Care 2018;41:1017-1024. Diabetes Care. 2018 07; 41(7):e125-e126.
    View in: PubMed
    Score: 0.017
  37. Racial/Ethnic Minority Youth With Recent-Onset Type 1 Diabetes Have Poor Prognostic Factors. Diabetes Care. 2018 05; 41(5):1017-1024.
    View in: PubMed
    Score: 0.016
  38. Heterogeneity of Type 1 Diabetes: The Effect of Ethnicity. Curr Diabetes Rev. 2018; 14(3):266-272.
    View in: PubMed
    Score: 0.016
  39. Genetics of type 1 diabetes. Pediatr Diabetes. 2018 05; 19(3):346-353.
    View in: PubMed
    Score: 0.016
  40. Genetic Risk Scores for Type 1 Diabetes Prediction and Diagnosis. Curr Diab Rep. 2017 Oct 28; 17(12):129.
    View in: PubMed
    Score: 0.016
  41. TCF7L2 Genetic Variants Contribute to Phenotypic Heterogeneity of Type 1 Diabetes. Diabetes Care. 2018 02; 41(2):311-317.
    View in: PubMed
    Score: 0.016
  42. Racial and ethnic differences among children with new-onset autoimmune Type 1 diabetes. Diabet Med. 2017 10; 34(10):1435-1439.
    View in: PubMed
    Score: 0.016
  43. Diabetes care provider perceptions on family challenges of pediatric type 1 diabetes. Diabetes Res Clin Pract. 2017 Jul; 129:203-205.
    View in: PubMed
    Score: 0.016
  44. Serum undercarboxylated osteocalcin correlates with hemoglobin A1c in children with recently diagnosed pediatric diabetes. Pediatr Diabetes. 2017 Dec; 18(8):869-873.
    View in: PubMed
    Score: 0.015
  45. Dissecting heterogeneity in paediatric Type 1 diabetes: association of TCF7L2 rs7903146 TT and low-risk human leukocyte antigen (HLA) genotypes. Diabet Med. 2017 02; 34(2):286-290.
    View in: PubMed
    Score: 0.014
  46. Psychosocial aspects of type 1 diabetes in Latino- and Asian-American youth. Pediatr Res. 2016 09; 80(3):347-55.
    View in: PubMed
    Score: 0.014
  47. DPD epitope-specific glutamic acid decarboxylase (GAD)65 autoantibodies in children with Type 1 diabetes. Diabet Med. 2017 05; 34(5):641-646.
    View in: PubMed
    Score: 0.014
  48. Prevalence of cardiovascular risk factors in youth with type 1 diabetes and elevated body mass index. Acta Diabetol. 2016 Apr; 53(2):271-7.
    View in: PubMed
    Score: 0.014
  49. Serum adiposity-induced biomarkers in obese and lean children with recently diagnosed autoimmune type 1 diabetes. Pediatr Diabetes. 2014 Dec; 15(8):543-9.
    View in: PubMed
    Score: 0.013
  50. Pediatric Diabetes Consortium Type 1 Diabetes New Onset (NeOn) Study: factors associated with HbA1c levels one year after diagnosis. Pediatr Diabetes. 2014 Jun; 15(4):294-302.
    View in: PubMed
    Score: 0.012
  51. Types of pediatric diabetes mellitus defined by anti-islet autoimmunity and random C-peptide at diagnosis. Pediatr Diabetes. 2013 Aug; 14(5):333-40.
    View in: PubMed
    Score: 0.012
  52. LADA: time for a new definition. Diabetes. 2013 Feb; 62(2):339-40.
    View in: PubMed
    Score: 0.012
  53. Beta cell function and BMI in ethnically diverse children with newly diagnosed autoimmune type 1 diabetes. Pediatr Diabetes. 2012 Nov; 13(7):564-71.
    View in: PubMed
    Score: 0.011
  54. What can we learn from patient-reported outcomes of insulin pen devices? J Diabetes Sci Technol. 2011 Nov 01; 5(6):1563-71.
    View in: PubMed
    Score: 0.011
  55. Therapeutics in pediatric diabetes: insulin and non-insulin approaches. Part of a series on Pediatric Pharmacology, guest edited by Gianvincenzo Zuccotti, Emilio Clementi, and Massimo Molteni. Pharmacol Res. 2012 Jan; 65(1):1-4.
    View in: PubMed
    Score: 0.011
  56. Concordance for islet autoimmunity among monozygotic twins. N Engl J Med. 2008 Dec 25; 359(26):2849-50.
    View in: PubMed
    Score: 0.009
  57. Specific human leukocyte antigen DQ influence on expression of antiislet autoantibodies and progression to type 1 diabetes. J Clin Endocrinol Metab. 2006 May; 91(5):1705-13.
    View in: PubMed
    Score: 0.007
  58. A Glucose Fraction Independent of Insulin Secretion: Implications for Type 1 Diabetes Progression in Autoantibody-Positive Cohorts. Diabetes Technol Ther. 2025 Mar; 27(3):179-186.
    View in: PubMed
    Score: 0.007
  59. Metabolic, genetic and immunological features of relatives of type 1 diabetes patients with elevated insulin resistance. J Endocrinol Invest. 2025 Mar; 48(3):765-775.
    View in: PubMed
    Score: 0.007
  60. Clinical Prediction Models Combining Routine Clinical Measures Have High Accuracy in Identifying Youth-Onset Type 2 Diabetes Defined by Maintained Endogenous Insulin Secretion: The SEARCH for Diabetes in Youth Study. Diabetes Care. 2024 Dec 01; 47(12):2110-2119.
    View in: PubMed
    Score: 0.007
  61. Identification of atypical pediatric diabetes mellitus cases using electronic medical records. BMJ Open Diabetes Res Care. 2024 Nov 07; 12(6).
    View in: PubMed
    Score: 0.007
  62. Expression of beta-cell autoimmunity does not differ between potential dizygotic twins and siblings of patients with type 1 diabetes. J Autoimmun. 2004 Nov; 23(3):275-9.
    View in: PubMed
    Score: 0.007
  63. Random C-Peptide and Islet Antibodies at Onset Predict ? Cell Function Trajectory and Insulin Dependence in Pediatric Diabetes. Endocr Pract. 2024 Dec; 30(12):1149-1157.
    View in: PubMed
    Score: 0.006
  64. Identification of type 1 diabetes risk phenotypes using an outcome-guided clustering analysis. Diabetologia. 2024 Nov; 67(11):2507-2517.
    View in: PubMed
    Score: 0.006
  65. Comparisons of Metabolic Measures to Predict T1D vs Detect a Preventive Treatment Effect in High-Risk Individuals. J Clin Endocrinol Metab. 2024 Jul 12; 109(8):2116-2123.
    View in: PubMed
    Score: 0.006
  66. A global initiative to deliver precision health in diabetes. Nat Med. 2024 Jul; 30(7):1819-1822.
    View in: PubMed
    Score: 0.006
  67. Early Metabolic Endpoints Identify Persistent Treatment Efficacy in Recent-Onset Type 1 Diabetes Immunotherapy Trials. Diabetes Care. 2024 Jun 01; 47(6):1048-1055.
    View in: PubMed
    Score: 0.006
  68. High Prevalence of A-?+ Ketosis-Prone Diabetes in Children with Type 2 Diabetes and Diabetic Ketoacidosis at Diagnosis: Evidence from the Rare and Atypical Diabetes Network (RADIANT). Pediatr Diabetes. 2024; 2024.
    View in: PubMed
    Score: 0.006
  69. Second international consensus report on gaps and opportunities for the clinical translation of precision diabetes medicine. Nat Med. 2023 Oct; 29(10):2438-2457.
    View in: PubMed
    Score: 0.006
  70. Plasma amino acid signatures define types of pediatric diabetes. Clin Nutr ESPEN. 2023 10; 57:21-28.
    View in: PubMed
    Score: 0.006
  71. Data Mining Framework for Discovering and Clustering Phenotypes of Atypical Diabetes. J Clin Endocrinol Metab. 2023 03 10; 108(4):834-846.
    View in: PubMed
    Score: 0.006
  72. Persistence of ?-Cell Responsiveness for Over Two Years in Autoantibody-Positive Children With Marked Metabolic Impairment at Screening. Diabetes Care. 2022 12 01; 45(12):2982-2990.
    View in: PubMed
    Score: 0.006
  73. The Transition From a Compensatory Increase to a Decrease in C-peptide During the Progression to Type 1 Diabetes and Its Relation to Risk. Diabetes Care. 2022 10 01; 45(10):2264-2270.
    View in: PubMed
    Score: 0.006
  74. Diabetic ketoacidosis at diabetes onset: still an all too common threat in youth. J Pediatr. 2013 Feb; 162(2):330-4.e1.
    View in: PubMed
    Score: 0.006
  75. Diabetes of Unclear Type in an Adolescent Boy With Multiple Islet-cell Autoantibody Positivity Successfully Managed With Glucagon-like Peptide-1 Receptor Agonist Alone: A Case Report. Can J Diabetes. 2023 Feb; 47(1):90-93.
    View in: PubMed
    Score: 0.006
  76. Genetic control of autoimmunity in Type I diabetes and associated disorders. Diabetologia. 2002 May; 45(5):605-22.
    View in: PubMed
    Score: 0.005
  77. Utility of Diabetes Type-Specific Genetic Risk Scores for the Classification of Diabetes Type Among Multiethnic Youth. Diabetes Care. 2022 05 01; 45(5):1124-1131.
    View in: PubMed
    Score: 0.005
  78. Optimizing maturity-onset diabetes of the young detection in a pediatric diabetes population. Pediatr Diabetes. 2022 06; 23(4):447-456.
    View in: PubMed
    Score: 0.005
  79. Contrast Pattern Mining With the T1D Exchange Clinic Registry Reveals Complex Phenotypic Factors and Comorbidity Patterns Associated With Familial Versus Sporadic Type 1 Diabetes. Diabetes Care. 2022 03 01; 45(3):e56-e59.
    View in: PubMed
    Score: 0.005
  80. Index60 Identifies Individuals at Appreciable Risk for Stage 3 Among an Autoantibody-Positive Population With Normal 2-Hour Glucose Levels: Implications for Current Staging Criteria of Type 1 Diabetes. Diabetes Care. 2022 02 01; 45(2):311-318.
    View in: PubMed
    Score: 0.005
  81. The pathogenesis, natural history, and treatment of type 1 diabetes: time (thankfully) does not stand still. Lancet Diabetes Endocrinol. 2022 02; 10(2):90-92.
    View in: PubMed
    Score: 0.005
  82. Exome sequencing in children with clinically suspected maturity-onset diabetes of the young. Pediatr Diabetes. 2021 11; 22(7):960-968.
    View in: PubMed
    Score: 0.005
  83. Time to Peak Glucose and Peak C-Peptide During the Progression to Type 1 Diabetes in the Diabetes Prevention Trial and TrialNet Cohorts. Diabetes Care. 2021 10; 44(10):2329-2336.
    View in: PubMed
    Score: 0.005
  84. Heterogeneity of type I diabetes: analysis of monozygotic twins in Great Britain and the United States. Diabetologia. 2001 Mar; 44(3):354-62.
    View in: PubMed
    Score: 0.005
  85. Genetics of type 1A diabetes. Recent Prog Horm Res. 2001; 56:69-89.
    View in: PubMed
    Score: 0.005
  86. The Effect of Ethnicity in the Rate of Beta-Cell Functional Loss in the First 3 Years After Type 1 Diabetes Diagnosis. J Clin Endocrinol Metab. 2020 12 01; 105(12).
    View in: PubMed
    Score: 0.005
  87. DR- and DQ-associated protection from type 1A diabetes: comparison of DRB1*1401 and DQA1*0102-DQB1*0602*. J Clin Endocrinol Metab. 2000 Oct; 85(10):3793-7.
    View in: PubMed
    Score: 0.005
  88. Diabetes Curriculum for Pediatric Endocrine Fellowship Utilizing Modified Team-Based Learning. MedEdPORTAL. 2020 08 13; 16:10948.
    View in: PubMed
    Score: 0.005
  89. Racial-Ethnic Inequity in Young Adults With Type 1 Diabetes. J Clin Endocrinol Metab. 2020 08 01; 105(8).
    View in: PubMed
    Score: 0.005
  90. Early and late C-peptide responses during oral glucose tolerance testing are oppositely predictive of type 1 diabetes in autoantibody-positive individuals. Diabetes Obes Metab. 2020 06; 22(6):997-1000.
    View in: PubMed
    Score: 0.005
  91. Excess BMI Accelerates Islet Autoimmunity in Older Children and Adolescents. Diabetes Care. 2020 03; 43(3):580-587.
    View in: PubMed
    Score: 0.005
  92. Medication-induced hyperglycemia: pediatric perspective. BMJ Open Diabetes Res Care. 2020 01; 8(1).
    View in: PubMed
    Score: 0.005
  93. Introducing the Endotype Concept to Address the Challenge of Disease Heterogeneity in Type 1 Diabetes. Diabetes Care. 2020 01; 43(1):5-12.
    View in: PubMed
    Score: 0.005
  94. Heterophile anti-mouse immunoglobulin antibodies may interfere with cytokine measurements in patients with HLA alleles protective for type 1A diabetes. Diabetes. 1999 Nov; 48(11):2166-70.
    View in: PubMed
    Score: 0.005
  95. Using Relational Agents to Promote Family Communication Around Type 1 Diabetes Self-Management in the Diabetes Family Teamwork Online Intervention: Longitudinal Pilot Study. J Med Internet Res. 2019 09 13; 21(9):e15318.
    View in: PubMed
    Score: 0.005
  96. Genetic determination of islet cell autoimmunity in monozygotic twin, dizygotic twin, and non-twin siblings of patients with type 1 diabetes: prospective twin study. BMJ. 1999 Mar 13; 318(7185):698-702.
    View in: PubMed
    Score: 0.004
  97. The Effect of Age on the Progression and Severity of Type 1 Diabetes: Potential Effects on Disease Mechanisms. Curr Diab Rep. 2018 09 26; 18(11):115.
    View in: PubMed
    Score: 0.004
  98. Adjuvant Pharmacotherapies to Insulin for the Treatment of Type 1 Diabetes. Curr Diab Rep. 2018 08 17; 18(10):79.
    View in: PubMed
    Score: 0.004
  99. Ethnic differences in progression of islet autoimmunity and type 1 diabetes in relatives at risk. Diabetologia. 2018 09; 61(9):2043-2053.
    View in: PubMed
    Score: 0.004
  100. Sex- and age-dependent effects of celiac disease on growth and weight gain in children with type 1 diabetes: Analysis of the type 1 diabetes Exchange Clinic Registry. Pediatr Diabetes. 2018 06; 19(4):741-748.
    View in: PubMed
    Score: 0.004
  101. The Role of Age and Excess Body Mass Index in Progression to Type 1 Diabetes in At-Risk Adults. J Clin Endocrinol Metab. 2017 12 01; 102(12):4596-4603.
    View in: PubMed
    Score: 0.004
  102. Nontraumatic lower extremity amputations in diabetic and non-diabetic subjects in Madrid, Spain. Diabetes Metab. 1997 Dec; 23(6):519-23.
    View in: PubMed
    Score: 0.004
  103. Streamlined Single Cell TCR Isolation and Generation of Retroviral Vectors for In Vitro and In Vivo Expression of Human TCRs. J Vis Exp. 2017 09 10; (127).
    View in: PubMed
    Score: 0.004
  104. Can Non-HLA Single Nucleotide Polymorphisms Help Stratify Risk in TrialNet Relatives at Risk for Type 1 Diabetes? J Clin Endocrinol Metab. 2017 08 01; 102(8):2873-2880.
    View in: PubMed
    Score: 0.004
  105. Excess BMI in Childhood: A Modifiable Risk Factor for Type 1 Diabetes Development? Diabetes Care. 2017 05; 40(5):698-701.
    View in: PubMed
    Score: 0.004
  106. Clinical outcomes in youth beyond the first year of type 1 diabetes: Results of the Pediatric Diabetes Consortium (PDC) type 1 diabetes new onset (NeOn) study. Pediatr Diabetes. 2017 Nov; 18(7):566-573.
    View in: PubMed
    Score: 0.004
  107. Rapid identification and expression of human TCRs in retrogenic mice. J Immunol Methods. 2016 12; 439:29-36.
    View in: PubMed
    Score: 0.004
  108. Nonaqueous, Mini-Dose Glucagon for Treatment of Mild Hypoglycemia in Adults With Type 1 Diabetes: A Dose-Seeking Study. Diabetes Care. 2016 Mar; 39(3):465-8.
    View in: PubMed
    Score: 0.004
  109. Depressive Symptoms in Youth With Type 1 or Type 2 Diabetes: Results of the Pediatric Diabetes Consortium Screening Assessment of Depression in Diabetes Study. Diabetes Care. 2015 Dec; 38(12):2341-3.
    View in: PubMed
    Score: 0.003
  110. Prediction and prevention of type 1 diabetes: update on success of prediction and struggles at prevention. Pediatr Diabetes. 2015 Nov; 16(7):465-84.
    View in: PubMed
    Score: 0.003
  111. Body mass index changes in youth in the first year after type 1 diabetes diagnosis. J Pediatr. 2015 May; 166(5):1265-1269.e1.
    View in: PubMed
    Score: 0.003
  112. The association of pattern of lifetime alcohol use and cause of death in the European prospective investigation into cancer and nutrition (EPIC) study. Int J Epidemiol. 2013 Dec; 42(6):1772-90.
    View in: PubMed
    Score: 0.003
  113. Pediatric diabetes consortium T1D New Onset (NeOn) study: clinical outcomes during the first year following diagnosis. Pediatr Diabetes. 2014 Jun; 15(4):287-93.
    View in: PubMed
    Score: 0.003
  114. Race, socioeconomic status, and treatment center are associated with insulin pump therapy in youth in the first year following diagnosis of type 1 diabetes. Diabetes Technol Ther. 2013 Nov; 15(11):929-34.
    View in: PubMed
    Score: 0.003
  115. Comparison of autoantibody-positive and autoantibody-negative pediatric participants enrolled in the T1D Exchange clinic registry. J Diabetes. 2013 Jun; 5(2):216-23.
    View in: PubMed
    Score: 0.003
  116. Body mass index at the time of diagnosis of autoimmune type 1 diabetes in children. J Pediatr. 2013 Apr; 162(4):736-740.e1.
    View in: PubMed
    Score: 0.003
  117. Dietary flavonoid and lignan intake and gastric adenocarcinoma risk in the European Prospective Investigation into Cancer and Nutrition (EPIC) study. Am J Clin Nutr. 2012 Dec; 96(6):1398-408.
    View in: PubMed
    Score: 0.003
  118. CAPN10 alleles modify laryngeal cancer risk in the Spanish population. Eur J Surg Oncol. 2008 Jan; 34(1):94-9.
    View in: PubMed
    Score: 0.002
  119. Genetic prediction of autoimmunity: initial oligogenic prediction of anti-islet autoimmunity amongst DR3/DR4-DQ8 relatives of patients with type 1A diabetes. J Autoimmun. 2005; 25 Suppl:40-5.
    View in: PubMed
    Score: 0.002
  120. Association of non-HLA genes with type 1 diabetes autoimmunity. Diabetes. 2005 Aug; 54(8):2482-6.
    View in: PubMed
    Score: 0.002
  121. Seasonality of month of birth of children and adolescents with type 1 diabetes mellitus in homogenous and heterogeneous populations. Isr Med Assoc J. 2005 Jun; 7(6):381-4.
    View in: PubMed
    Score: 0.002
  122. Celiac disease associated with type 1 diabetes mellitus. Endocrinol Metab Clin North Am. 2004 Mar; 33(1):197-214, xi.
    View in: PubMed
    Score: 0.002
  123. Insulin autoimmunity: prediction/precipitation/prevention type 1A diabetes. Autoimmun Rev. 2002 May; 1(3):139-45.
    View in: PubMed
    Score: 0.001
  124. Reanalysis of twin studies suggests that diabetes is mainly genetic. BMJ. 2001 Oct 27; 323(7319):997-8.
    View in: PubMed
    Score: 0.001
  125. Pathology teach and tell: vaginal mesonephric papilloma. Pediatr Pathol Mol Med. 2001 Jul-Aug; 20(4):341-4.
    View in: PubMed
    Score: 0.001
  126. Self-antigen-presenting cells expressing diabetes-associated autoantigens exist in both thymus and peripheral lymphoid organs. J Clin Invest. 2001 Mar; 107(5):555-64.
    View in: PubMed
    Score: 0.001
  127. Comparative in vitro activities of linezolid, quinupristin-dalfopristin, moxifloxacin, and trovafloxacin against erythromycin-susceptible and -resistant streptococci. Antimicrob Agents Chemother. 2000 Jul; 44(7):1838-41.
    View in: PubMed
    Score: 0.001
  128. Modification of the environment is not the most efficient way to prevent type 1 diabetes. Diabetes Technol Ther. 2000; 2(4):609-16.
    View in: PubMed
    Score: 0.001
  129. [Parenteral nutrition of patients under intensive chemotherapy: comparative study of two lipid emulsions]. Nutr Hosp. 1998 Jul-Aug; 13(4):177-80.
    View in: PubMed
    Score: 0.001
  130. Dual-parameter model for prediction of type I diabetes mellitus. Proc Assoc Am Physicians. 1998 Mar-Apr; 110(2):126-35.
    View in: PubMed
    Score: 0.001
  131. Primary intrasellar germinoma with synchronous pineal tumor. Neuroradiology. 1997 Dec; 39(12):860-2.
    View in: PubMed
    Score: 0.001
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.